Inventor · disambiguated record
John Bridgeman
Also filed as: BRIDGEMAN JOHN · BRIDGEMAN JOHN STEPHEN
5 granted patents·10 pending applications·6 citations·filing 2016–2023
71Inventor score
Top patents by PatentIndex Score
15 records- 0187US12187778B2Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Granted Jan 7, 2025·1 cites·13 claims
- 0287US11945876B2Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Granted Apr 2, 2024·2 cites·14 claims
- 0386US11697677B2Chimeric molecules providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Granted Jul 11, 2023·2 cites·25 claims
- 0471US12116564B2Cells expressing recombinant growth factor receptorsINSTIL BIO UK LTD·Filed 2022·Granted Oct 15, 2024·0 cites·12 claims
- 0571US11530386B2Cells expressing recombinant growth factor receptorsINSTIL BIO UK LTD·Filed 2016·Granted Dec 20, 2022·1 cites·22 claims
- 0663US2022348631A1Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Application pending·0 cites
- 0763US2023331808A1Chimeric molecules providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2023·Application pending·0 cites
- 0863US2023055694A1Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2022·Application pending·0 cites
- 0962US2024058447A1Use of fusion constructs for il-2 independent t cell therapyINSTIL BIO UK LTD·Filed 2023·Application pending·0 cites
- 1056US2023227576A1Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2023·Application pending·0 cites
- 1154US2022160760A1Receptors providing targeted costimulation for adoptive cell therapyINSTIL BIO UK LTD·Filed 2021·Application pending·0 cites
- 1253US2023277670A1Chimeric molecules providing targeted costimulation for adoptive cell therapyBRIDGEMAN JOHN·Filed 2021·Application pending·0 cites
- 1351US2022378826A1Tumour infiltrating lymphocyte therapy and uses thereofINSTIL BIO UK LTD·Filed 2022·Application pending·0 cites
- 1444US2021205365A1Chimeric Growth Factor ReceptorsINSTIL BIO UK LTD·Filed 2020·Application pending·0 cites
- 1542US2021000872A1Biomarker predictive of tumour infiltrating lymphocyte therapy and uses thereofINSTIL BIO UK LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Bridgeman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →